{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:08:58Z","timestamp":1789474138923,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006727","name":"University of Kansas Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K22CA184146"],"award-info":[{"award-number":["K22CA184146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20 GM103549"],"award-info":[{"award-number":["P20 GM103549"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103418"],"award-info":[{"award-number":["P20GM103418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM118247"],"award-info":[{"award-number":["P30GM118247"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK119131"],"award-info":[{"award-number":["R01DK119131"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32ES007079"],"award-info":[{"award-number":["T32ES007079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002366"],"award-info":[{"award-number":["UL1 TR002366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["16-194-07"],"award-info":[{"award-number":["16-194-07"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.livres.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T02:30:14Z","timestamp":1669084214000},"page":"238-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Nancy","family":"Magee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-4573","authenticated-orcid":false,"given":"Forkan","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Eppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-7277","authenticated-orcid":false,"given":"Elizabeth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-7420","authenticated-orcid":false,"given":"Priyanka","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-3583","authenticated-orcid":false,"given":"Yuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.livres.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A\u00a0systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.11.001_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"Tetri","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","article-title":"High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis","volume":"52","author":"Kohli","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"Clapper","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","article-title":"Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis","volume":"26","author":"Mells","year":"2015","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.livres.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1074\/jbc.RA117.001653","article-title":"Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"293","author":"Zou","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00077.2013","article-title":"Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease","volume":"305","author":"Smalling","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmet.2018.12.004","article-title":"Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi","volume":"20","author":"Xiong","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1038\/s41598-018-25743-8","article-title":"Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2022.11.001_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A\u00a0diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41598-018-36163-z","article-title":"RAGE is a critical mediator of pulmonary oxidative stress, alveolar macrophage activation and emphysema in response to cigarette smoke","volume":"9","author":"Sanders","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.livres.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.livres.2022.11.001_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5170402","article-title":"Pathogenesis of nonalcoholic steatohepatitis: interactions between liver parenchymal and nonparenchymal cells","volume":"2016","author":"Magee","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.livres.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/JVI.80.8.3985-3993.2006","article-title":"In\u00a0vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses","volume":"80","author":"Kassim","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.livres.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50976-6","article-title":"Depletion of CD40 on CD11c(+) cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH","volume":"9","author":"Aarts","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes","volume":"19","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli Pvidela","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib32","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Moran-Salvador","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmet.2008.03.003","article-title":"Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27","volume":"7","author":"Matsusue","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPARgamma-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Wolf Greenstein","year":"2017","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.livres.2022.11.001_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-016-0321-5","article-title":"Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease","volume":"15","author":"Paglialunga","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.livres.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1042\/CS20171208","article-title":"Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets","volume":"131","author":"Umpleby","year":"2017","journal-title":"Clin Sci"},{"key":"10.1016\/j.livres.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.11.001_bib39","first-page":"582","article-title":"Pharmacologic management of nonalcoholic steatohepatitis","volume":"14","author":"Neuschwander-Tetri","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib41","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents","volume":"118","author":"Ota","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2022.11.001_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.devcel.2008.10.015","article-title":"UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators","volume":"15","author":"Rutkowski","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.livres.2022.11.001_bib44","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.livres.2022.11.001_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib46","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/S0021-9258(17)34693-8","article-title":"Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA","volume":"253","author":"McGarry","year":"1978","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.11.001_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI108764","article-title":"A\u00a0possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis","volume":"60","author":"McGarry","year":"1977","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","article-title":"Malonyl-CoA: the regulator of fatty acid synthesis and oxidation","volume":"122","author":"Foster","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.11.001_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.livres.2022.11.001_bib51","first-page":"31","article-title":"The role of innate immune cells in nonalcoholic fatty liver disease","volume":"14","author":"Nati","year":"2022","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.livres.2022.11.001_bib52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.livres.2022.11.001_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.11.001_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.760860","article-title":"Emerging roles of T cells in the pathogenesis of nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"12","author":"Hirsova","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.livres.2022.11.001_bib55","doi-asserted-by":"crossref","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.11.001_bib56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4161\/cc.10.3.14709","article-title":"Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models","volume":"10","author":"Kalin","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.livres.2022.11.001_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.01.012","article-title":"Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis","volume":"462","author":"Saavedra-Garcia","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.livres.2022.11.001_bib59","first-page":"92","article-title":"FoxM1: at the crossroads of ageing and cancer","volume":"1775","author":"Laoukili","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2022.11.001_bib60","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2017.5472","article-title":"FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression","volume":"37","author":"Shang","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.livres.2022.11.001_bib61","doi-asserted-by":"crossref","first-page":"21022","DOI":"10.18632\/oncotarget.24781","article-title":"Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma","volume":"9","author":"Ogura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.livres.2022.11.001_bib62","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cmet.2017.02.004","article-title":"Insulin signaling regulates the FoxM1\/PLK1\/CENP-A pathway to promote adaptive pancreatic beta cell proliferation","volume":"25","author":"Shirakawa","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.11.001_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccell.2017.06.002","article-title":"Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma","volume":"32","author":"Dang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.livres.2022.11.001_bib64","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3892\/or.2012.1821","article-title":"Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma","volume":"28","author":"Iida","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.livres.2022.11.001_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2022.11.001_bib66","doi-asserted-by":"crossref","first-page":"nzab138","DOI":"10.1093\/cdn\/nzab138","article-title":"Considerations when choosing high-fat, high-fructose, and high-cholesterol diets to induce experimental nonalcoholic fatty liver disease in laboratory animal models","volume":"5","author":"Radhakrishnan","year":"2021","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.livres.2022.11.001_bib67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.livres.2022.11.001_bib68","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:20Z","timestamp":1762872380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568422000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2542568422000605"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2022.11.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}